Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study
HER2DX(一种基于算法的基因组诊断方法)对早期HER2阳性乳腺癌临床决策的影响:一项前瞻性真实世界研究的结果
期刊:
影响因子:
doi:10.1016/j.esmorw.2025.100123
Martínez-Sáez, O; Tapia, M; Marín-Aguilera, M; Hernández-Illán, E; Tébar, C; Martinez-Puchol, A I; Jares, P; Marín-Liébana, S; Magro, A; Puig-Butille, J A; Palomar, L; Sanfeliu, E; Martinez, M T; Losada, M V; Hernando, C; Adamo, B; Iranzo, V; Pascual, T; Pouptsis, A; Schettini, F; Santaballa, A; Conte, B; Torregrosa, M D; Brasó-Maristany, F; Walbaum, B; Gómez-Bravo, R; Burgués, O; Fructuoso, I G; Garrido-Cano, I; Seguí, E; Paré, L; Muñoz, M; Carcelero, E; Sànchez, J; Villagrasa-González, P; Buckingham, W; Prat, A; Villacampa, G; Chic, N; Rivera, P; Rezqallah, A; Saura, C; Escrivà, S; Bermejo, B; Lluch, A; Llombart, A; Cejalvo, J M